SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
FRA:SHL - Deutsche Boerse Ag - DE000SHL1006 - Common Stock - Currency: EUR
Overall SHL gets a fundamental rating of 5 out of 10. We evaluated SHL against 57 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
In the past year SHL had a positive cash flow from operations.
SHL had positive earnings in each of the past 5 years.
In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.45%, SHL is in the better half of the industry, outperforming 64.91% of the companies in the same industry.
SHL has a better Return On Equity (11.19%) than 75.44% of its industry peers.
With a decent Return On Invested Capital value of 7.37%, SHL is doing good in the industry, outperforming 68.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 8.57%.
The last Return On Invested Capital (7.37%) for SHL is above the 3 year average (5.87%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.45% | ||
| ROE | 11.19% | ||
| ROIC | 7.37% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
With a decent Profit Margin value of 9.03%, SHL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
SHL's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 13.67%, SHL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of SHL has declined.
SHL's Gross Margin of 38.77% is on the low side compared to the rest of the industry. SHL is outperformed by 75.44% of its industry peers.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.67% | ||
| PM (TTM) | 9.03% | ||
| GM | 38.77% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
The number of shares outstanding for SHL has been increased compared to 1 year ago.
Compared to 5 years ago, SHL has more shares outstanding
SHL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.91 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
SHL's Altman-Z score of 1.91 is in line compared to the rest of the industry. SHL outperforms 47.37% of its industry peers.
The Debt to FCF ratio of SHL is 6.06, which is on the high side as it means it would take SHL, 6.06 years of fcf income to pay off all of its debts.
SHL's Debt to FCF ratio of 6.06 is in line compared to the rest of the industry. SHL outperforms 54.39% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that SHL is somewhat dependend on debt financing.
SHL's Debt to Equity ratio of 0.65 is on the low side compared to the rest of the industry. SHL is outperformed by 70.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.06 | ||
| Altman-Z | 1.91 |
ROIC/WACC1.19
WACC6.2%
2.3 Liquidity
A Current Ratio of 1.10 indicates that SHL should not have too much problems paying its short term obligations.
SHL has a worse Current ratio (1.10) than 75.44% of its industry peers.
A Quick Ratio of 0.76 indicates that SHL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.76, SHL is doing worse than 71.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.76 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.21% over the past year.
Measured over the past 5 years, SHL shows a small growth in Earnings Per Share. The EPS has been growing by 7.27% on average per year.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 3.15%.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)3.15%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.21% yearly.
The Revenue is expected to grow by 5.64% on average over the next years.
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y10.21%
Revenue Next Year4.98%
Revenue Next 2Y5.11%
Revenue Next 3Y5.47%
Revenue Next 5Y5.64%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.44, SHL is valued on the expensive side.
Based on the Price/Earnings ratio, SHL is valued cheaper than 85.96% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.41, SHL is valued a bit cheaper.
With a Price/Forward Earnings ratio of 16.22, SHL is valued correctly.
77.19% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
SHL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 33.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.44 | ||
| Fwd PE | 16.22 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 66.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaper than 89.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.77 | ||
| EV/EBITDA | 14.9 |
4.3 Compensation for Growth
SHL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
SHL has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SHL's earnings are expected to grow with 12.78% in the coming years.
PEG (NY)1.59
PEG (5Y)2.67
EPS Next 2Y13.11%
EPS Next 3Y12.78%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.06%.
Compared to an average industry Dividend Yield of 2.09, SHL pays a better dividend. On top of this SHL pays more dividend than 82.46% of the companies listed in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.06% |
5.2 History
The dividend of SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
SHL pays out 101.91% of its income as dividend. This is not a sustainable payout ratio.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP101.91%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
FRA:SHL (8/12/2025, 5:35:30 PM)
46.27
+0.38 (+0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap52.19B
Analysts83.7
Price Target61.73 (33.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.06% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP101.91%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.12%
Min EPS beat(2)-2.04%
Max EPS beat(2)8.28%
EPS beat(4)2
Avg EPS beat(4)2.45%
Min EPS beat(4)-2.04%
Max EPS beat(4)8.28%
EPS beat(8)5
Avg EPS beat(8)1.99%
EPS beat(12)7
Avg EPS beat(12)1.43%
EPS beat(16)10
Avg EPS beat(16)3.47%
Revenue beat(2)2
Avg Revenue beat(2)0.78%
Min Revenue beat(2)0.27%
Max Revenue beat(2)1.29%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-3.02%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.42%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)9
Avg Revenue beat(16)0.75%
PT rev (1m)-0.77%
PT rev (3m)-3.07%
EPS NQ rev (1m)4.16%
EPS NQ rev (3m)-4.8%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.35%
Revenue NQ rev (3m)-3.57%
Revenue NY rev (1m)-0.68%
Revenue NY rev (3m)-0.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.44 | ||
| Fwd PE | 16.22 | ||
| P/S | 2.26 | ||
| P/FCF | 18.77 | ||
| P/OCF | 14.73 | ||
| P/B | 2.8 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.9 |
EPS(TTM)2.38
EY5.14%
EPS(NY)2.85
Fwd EY6.17%
FCF(TTM)2.46
FCFY5.33%
OCF(TTM)3.14
OCFY6.79%
SpS20.52
BVpS16.55
TBVpS-5.76
PEG (NY)1.59
PEG (5Y)2.67
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.45% | ||
| ROE | 11.19% | ||
| ROCE | 9.41% | ||
| ROIC | 7.37% | ||
| ROICexc | 8.05% | ||
| ROICexgc | 44.05% | ||
| OM | 13.67% | ||
| PM (TTM) | 9.03% | ||
| GM | 38.77% | ||
| FCFM | 12.01% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.06 | ||
| Debt/EBITDA | 2.78 | ||
| Cap/Depr | 62.49% | ||
| Cap/Sales | 3.3% | ||
| Interest Coverage | 7.53 | ||
| Cash Conversion | 80.8% | ||
| Profit Quality | 133.08% | ||
| Current Ratio | 1.1 | ||
| Quick Ratio | 0.76 | ||
| Altman-Z | 1.91 |
F-Score8
WACC6.2%
ROIC/WACC1.19
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y12.21%
EPS Next 2Y13.11%
EPS Next 3Y12.78%
EPS Next 5Y10.21%
Revenue 1Y (TTM)3.15%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.98%
Revenue Next 2Y5.11%
Revenue Next 3Y5.47%
Revenue Next 5Y5.64%
EBIT growth 1Y21.23%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.6%
EBIT Next 3Y21.79%
EBIT Next 5Y15.59%
FCF growth 1Y102.62%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y57.68%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%